All products / DC23022
PDZ1i
Pack sizes and prices
| Pack size | Price |
|---|---|
| 100 mg | $1,500 USDRequest a quote → |
In stock. Contact our team for lead time, shipping and final quotation.
Product overview
PDZ1i (113B7) is a specific inhibitor of MDA-9/Syntenin activity that inhibits MDA-9/Syntenin binding to EGFRvIII; selectively binds with micromolar affinity to the PDZ1 domain of MDA-9/Syntenin, with no affinity for PDZ2 domain of MDA-9/Syntenin; reduces invasion gains in GBM cells following radiation, inhibits crucial GBM signaling involving FAK and mutant EGFR, EGFRvIII, and abrogated gains in secreted proteases, MMP-2 and MMP-9, following radiation; results in smaller, less invasive tumors and enhanced survival in an in vivo glioma model.
For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.
Identity and specifications
| Catalog number | DC23022 |
|---|---|
| Product name | PDZ1i |
| CAS | 2083618-79-3 |
| Molecular formula | C28H26N8O4 |
| Molecular weight | 538.5572 |
| Purity | >98% |
| SMILES | O=C1C2=C(C([H])([H])C([H])([H])C2([H])[H])N=C2N=C(C(N([H])C3=C([H])C(C([H])([H])[H])=C(C([H])=C3C([H])([H])[H])N([H])C(C([H])([H])C([H])([H])C3=NN=C(C4C([H])=C([H])C([H])=C([H])C=4[H])O3)=O)=O)N([H])N12 |
Source-listed specifications; the batch COA applies.
Source and product documents
The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.
DC Chemicals — PDZ1i (DC23022)Source references
References 1. Kegelman TP, et al. Proc Natl Acad Sci U S A. 2017 Jan 10;114(2):370-375. View Related Products by Target Other Targets
